Success Metrics

Clinical Success Rate
90.9%

Based on 30 completed trials

Completion Rate
91%(30/33)
Active Trials
2(4%)
Results Posted
3%(1 trials)
Terminated
3(7%)

Phase Distribution

Ph phase_1
1
2%
Ph phase_3
6
13%
Ph phase_4
3
7%
Ph not_applicable
21
46%
Ph phase_2
1
2%
Ph early_phase_1
1
2%

Phase Distribution

2

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution33 total trials
Early Phase 1First-in-human
1(3.0%)
Phase 1Safety & dosage
1(3.0%)
Phase 2Efficacy & side effects
1(3.0%)
Phase 3Large-scale testing
6(18.2%)
Phase 4Post-market surveillance
3(9.1%)
N/ANon-phased studies
21(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

30 of 36 finished

Non-Completion Rate

16.7%

6 ended early

Currently Active

2

trials recruiting

Total Trials

46

all time

Status Distribution
Active(4)
Completed(30)
Terminated(6)
Other(6)

Detailed Status

Completed30
unknown6
Withdrawn3
Terminated3
Not yet recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
46
Active
2
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.0%)
Phase 11 (3.0%)
Phase 21 (3.0%)
Phase 36 (18.2%)
Phase 43 (9.1%)
N/A21 (63.6%)

Trials by Status

withdrawn37%
completed3065%
not_yet_recruiting24%
recruiting24%
terminated37%
unknown613%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT06790784Phase 3

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

Recruiting
NCT07140692Not Applicable

EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE

Completed
NCT07105072Not Applicable

Vitrectomy Versus Suprachoroidal Steroid in Trematodal Granulomatous Uveitis

Completed
NCT04522661Not Applicable

A Feasibility Randomised Controlled Trial of Early Vitrectomy for Post-operative Exogenous Endophthalmitis

Completed
NCT06997874Phase 3

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

Recruiting
NCT06610786Not Applicable

Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment

Not Yet Recruiting
NCT05583331Not Applicable

Comparison of Two Surgical Sequences "Cataract Surgery Then Vitrectomy" Versus "Vitrectomy Then Cataract Surgery" Under Local-regional Anesthesia

Completed
NCT01023009

Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion

Terminated
NCT01022879Early Phase 1

Topical Anesthesia in Small Gauge Vitrectomy

Terminated
NCT00404209Phase 3

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

Terminated
NCT00563121Phase 4

VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V

Withdrawn
NCT00407108Phase 3

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Withdrawn
NCT06316388

Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema

Not Yet Recruiting
NCT01478737Phase 2

Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Completed
NCT05583253Not Applicable

Visual Outcome of Vitrectomy After Refractive Surgery

Unknown
NCT03318588

Intravitreous CytokinE Level in pAtient With retiNal Detachment

Completed
NCT05069675

Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment

Unknown
NCT03603990Not Applicable

Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema

Withdrawn
NCT02639507

International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients

Completed
NCT04153253Phase 4

Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
46